(Press-News.org) Rheumatoid arthritis appears three times more often in women
Women need to know whether they can stop taking drugs while pregnant
Genetic markers could predict who will improve and who will worsen during pregnancy
When women with rheumatoid arthritis (RA) plan to become pregnant, many anguish over whether to stop their medications, risking a flareup in their disease, or continue with medication and risk possible harm to the baby.
About 50% to 75% will see their disease naturally improve during pregnancy for not-yet-known reasons, while others may see a worsening of their RA. But they have had no way of knowing which would happen to them.
Now, Northwestern Medicine scientists have identified, for the first time, genetic markers before pregnancy that could predict who will improve and who will worsen.
The study was published this week in Arthritis Research & Therapy.
RA is an incurable disease that affects 1% of the adult world population and occurs three times more often among women. It leads to significant disability as a result of inflammation of the joints as well as destruction of cartilage and bone.
“When women with RA go through pregnancy, there often is a natural improvement,” said lead study investigator Damini Jawaheer, research associate professor of medicine in rheumatology at Northwestern University Feinberg School of Medicine. “They describe it as ‘a miracle.’ They say ‘I have never felt this good with any medication I have taken.’ But the cause of this improvement is a complete mystery.
“If women with RA can know in advance whether they are likely to see their disease disappear during pregnancy, they know they can go off their drugs. Some RA drugs are toxic and affect the fetus, while others are considered safe. But some women with RA don’t want to take any drugs during pregnancy, not even the ones considered safe.”
Being able to predict who will improve and who will worsen will help women in their pregnancy planning and will also help to focus treatment during pregnancy only to those women who are predicted to worsen, Jawaheer said. Furthermore, women who are predicted to improve and their fetus will not be unnecessarily exposed to medications.
Jawaheer and her team found that, before pregnancy, a group of white blood cells called neutrophils were highly expressed among the women who improved during pregnancy, and some genes related to B cells were highly expressed among women who worsened.
This field has not been well studied partly because it is difficult to find women for a pregnancy study before they get pregnant, Jawaheer said.
She and colleagues were able to conduct the study because they’d previously established a unique pregnancy cohort in Denmark, which enrolled women with RA and healthy women before pregnancy and followed them over time to determine who improved and who worsened during pregnancy. Using blood samples collected from those women before pregnancy, they examined the levels of different genes expressed in the blood. Blood samples were collected before pregnancy from 19 women with RA and 13 healthy women enrolled in the prospective pregnancy cohort.
Next, Jawaheer plans to conduct a study in a larger cohort of women to validate these findings. Additionally, her lab is trying to figure out why RA improves during pregnancy.
“How is nature making an incurable disease go away?” she asked. “If we can understand how pregnancy induces a natural improvement, we can use that as a model to develop a new medication that would be safer and could improve the lives of the women and men living with this terrible disease.”
The name of the paper is “Pre-pregnancy gene expression signatures are associated with subsequent improvement/worsening of rheumatoid arthritis during pregnancy.”
The other Northwestern author is Matthew Wright.
The study was funded by grants R21AR057931 and R01AR073111 from the National Institute of Arthritis, Musculoskeletal and Skin Diseases of the National Institutes of Health and by Gigtforeningen and Juliane Marie Center in Denmark.
END
Settling a half century of debate, researchers have discovered that tiny linear defects can propagate through a material faster than sound waves do.
These linear defects, or dislocations, are what give metals their strength and workability, but they can also make materials fail catastrophically – which is what happens every time you pop the pull tab on a can of soda.
The fact that they can travel so fast gives scientists a new appreciation of the unusual types of damage they might do to a broad range of materials in extreme conditions – from rock ripped apart ...
A new attempt to predict earthquakes with the aid of artificial intelligence has raised hopes that the technology could one day be used to limit earthquakes’ impact on lives and economies. Developed by researchers at The University of Texas at Austin, the AI algorithm correctly predicted 70% of earthquakes a week before they happened during a seven-month trial in China.
The AI was trained to detect statistical bumps in real-time seismic data that researchers had paired with previous earthquakes. The outcome was a weekly forecast in which the AI successfully predicted 14 earthquakes within about 200 miles of where it estimated they would happen and at almost exactly the ...
MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.
Images
Highlights:
New Michigan State University research published in the journal Proceedings of the National Academy of Sciences shows that plants such as oak and poplar trees will emit more of a compound called isoprene as global temperatures climb.
Isoprene from plants represents the highest flux of hydrocarbons to the atmosphere behind methane.
Although isoprene isn’t inherently bad — it actually helps plants better tolerate insect pests and high temperatures — it can worsen air pollution by reacting ...
The purpose of the award is to create the Access for All in ALS (ALL ALS) Consortium to conduct clinical research that will include ALS patients nationwide, generating a longitudinal biorepository linked to detailed clinical information that will be made available to research scientists throughout the world using a web-based portal. As part of this new consortium Barrow will manage half of 34 clinical sites in the study which spans the U.S. and Puerto Rico. The consortium will be led by researchers at Barrow, Massachusetts General Hospital and Columbia University.
“Barrow Neurological Institute is honored to be selected by the NIH to help coordinate this ...
Many people fail at achieving their early career dreams. But a new study suggests that those failures don’t have to harm your self-esteem if you think about them in the right way.
Researchers found that people who viewed career goal failures as a steppingstone to new opportunities never lost self-esteem, no matter how many times they failed. But those who thought their failures left them worse off showed a drop-off in how they felt about themselves.
“It’s not how many times you have had to give up. It is how you felt about the failures, and whether you thought they led to something better for you,” ...
Pathology experts engineered an ultrasensitive test capable of detecting a highly specific biomarker found in multiple common cancers
In collaboration with cancer researchers across the country and the globe, the team evaluated the tool’s ability to detect the biomarker in ovarian cancer, gastroesophageal cancer, colon cancer, and other cancers
Diagnostic assays have potential for early cancer detection, monitoring, and prognostics
Marker ‘LINE-1 ORF1p’ is a protein encoded by a human transposon that has further potential applications in tissue diagnostics and may also facilitate treatment of cancers for which no accurate biomarkers ...
Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine (“Insilico”) will present at the 6th LSX Nordic Conference happening in Copenhagen Oct. 10-11. Zhavoronkov, a leader in generative artificial intelligence (AI) technologies for drug discovery and biomarker development, will present on Oct. 11, 2pm CET on “‘How Artificial Intelligence is Shaping the Future of Drug Discovery, Design, and Development.”
The LSX Nordic Congress is a leading strategy, investment and partnering conference for the Nordic region connecting life science and healthcare ...
In a recent randomized, controlled human study, consuming grapes for 16 weeks improved key markers of eye health in older adults. The study, published in the scientific journal Food & Function looked at the impact of regular consumption of grapes on macular pigment accumulation and other biomarkers of eye health.[1] This is the first human study on this subject, and the results reinforce earlier, preliminary studies where consuming grapes was found to protect retinal structure and function.[2]
Science has shown that an aging population has a higher risk of eye disease and vision problems. Key risk factors for eye disease include 1) oxidative ...
When we’re married or in a long-term romantic relationship, we may eventually come to take each other for granted and forget to show appreciation. A new study from the University of Illinois Urbana-Champaign finds that it doesn’t have to stay this way.
The study examined why perceived gratitude from a spouse or romantic partner changes over time, and whether it can be improved through relationship intervention programs.
“Gratitude almost seems to be a secret sauce to relationships, and an important piece to the puzzle of romantic relationships that hasn’t gotten much attention ...
The 2021 results began a global conversation that sparked public imagination and incited dissenting commentary throughout the scientific community as to the accuracy of the ages.
“The immediate reaction in some circles of the archeological community was that the accuracy of our dating was insufficient to make the extraordinary claim that humans were present in North America during the Last Glacial Maximum. But our targeted methodology in this current research really paid off,” said Jeff Pigati, USGS research geologist ...
